Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk
Open Access
- 8 January 2013
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 1-9
Abstract
Background: Vitamin K has been related to glucose metabolism, insulin sensitivity and diabetes. Because inflammation underlies all these metabolic conditions, it is plausible that the potential role of vitamin K in glucose metabolism occurs through the modulation of cytokines and related molecules. The purpose of the study was to assess the associations between dietary intake of vitamin K and peripheral adipokines and other metabolic risk markers related to insulin resistance and type 2 diabetes mellitus. Methods: Cross-sectional and longitudinal assessments of these associations in 510 elderly participants recruited in the PREDIMED centers of Reus and Barcelona (Spain). We determined 1-year changes in dietary phylloquinone intake estimated by food frequency questionnaires, serum inflammatory cytokines and other metabolic risk markers. Results: In the cross-sectional analysis at baseline no significant associations were found between dietary phylloquinone intake and the rest of metabolic risk markers evaluated, with exception of a negative association with plasminogen activator inhibitor-1. After 1-year of follow-up, subjects in the upper tertile of changes in dietary phylloquinone intake showed a greater reduction in ghrelin (−15.0%), glucose-dependent insulinotropic peptide (−12.9%), glucagon-like peptide-1 (−17.6%), IL-6 (−27.9%), leptin (−10.3%), TNF (−26.9%) and visfatin (−24.9%) plasma concentrations than those in the lowest tertile (all p<0.05). Conclusion: These results show that dietary phylloquinone intake is associated with an improvement of cytokines and other markers related to insulin resistance and diabetes, thus extending the potential protection by dietary phylloquinone on chronic inflammatory diseases. Trial registration: http://www.controlled-trials.com as ISRCTN35739639Keywords
This publication has 34 references indexed in Scilit:
- Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular diseaseThe American Journal of Clinical Nutrition, 2012
- Bone quality and vitamin K2 in type 2 diabetes: Review of preclinical and clinical studiesNutrition Reviews, 2011
- Effect of phylloquinone supplementation on glucose homeostasis in humansThe American Journal of Clinical Nutrition, 2010
- Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 DiabetesDiabetes Care, 2010
- Roles for Vitamin K Beyond CoagulationAnnual Review of Nutrition, 2009
- Vitamin K, circulating cytokines, and bone mineral density in older men and womenThe American Journal of Clinical Nutrition, 2008
- Phylloquinone intake, insulin sensitivity, and glycemic status in men and womenThe American Journal of Clinical Nutrition, 2008
- Vitamin K and Vitamin D Status: Associations with Inflammatory Markers in the Framingham Offspring StudyAmerican Journal of Epidemiology, 2007
- Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the RatBioscience, Biotechnology, and Biochemistry, 2006
- The roles of vitamins D and K in bone health and osteoporosis preventionProceedings of the Nutrition Society, 1997